Acquired by Merck Next generation T-cell engaging biologics targeting cancer and other diseases based on its proprietary TriTACâ„¢ platform South San Francisco, CA NASDAQ: HARP
Commercial stage device company with innovative technology for the non-invasive, non-pharmacologic treatment of major depression. Malverne, PA NASD: STIM
Recent Comments